Henry Schein (NASDAQ:HSIC) Releases FY 2025 Earnings Guidance

Henry Schein (NASDAQ:HSIC) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share guidance of 4.800-4.940 for the period, compared to the consensus earnings per share estimate of 4.970. The company issued revenue guidance of $12.4 billion-$13.2 billion, compared to the consensus revenue estimate of $13.2 billion. Henry Schein also updated its FY25 guidance to $4.80-4.94 EPS.

Analyst Ratings Changes

HSIC has been the topic of several recent analyst reports. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Jefferies Financial Group increased their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research report on Thursday, January 23rd. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. Barrington Research raised their target price on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Finally, Mizuho initiated coverage on Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target for the company. Eight research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and a consensus price target of $80.09.

Henry Schein Price Performance

HSIC traded down $3.64 during trading on Tuesday, reaching $74.00. 835,245 shares of the company traded hands, compared to its average volume of 1,538,078. The company has a market cap of $9.23 billion, a P/E ratio of 30.30, a PEG ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63. The firm has a fifty day simple moving average of $74.19 and a 200 day simple moving average of $72.38.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. Henry Schein’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.66 earnings per share. On average, equities analysts forecast that Henry Schein will post 4.74 EPS for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.